questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins atténués
Vaccins atténués : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
2
Vaccins atténués
Agents pathogènes
Immunisation
Tests sérologiques
Efficacité des vaccins
Immunité
Symptômes
2
Réactions aux vaccins
Effets secondaires
Fièvre
Maladies infectieuses
Réactions indésirables
Vaccins
Prévention
2
Préparation à la vaccination
Antécédents médicaux
Vaccins
Immunodépression
Sécurité des vaccins
Vaccins atténués
Traitements
2
Réactions allergiques
Traitement médical
Vaccins
Antécédents médicaux
Prévention
Vaccins
Complications
2
Complications
Infections
Vaccins atténués
Surveillance médicale
Effets indésirables
Vaccins
Facteurs de risque
2
Immunodépression
Grossesse
Vaccins atténués
Allergies
Évaluation médicale
Vaccins
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins atténués : Questions médicales les plus fréquentes",
"headline": "Vaccins atténués : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins atténués : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-19",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins atténués"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins",
"url": "https://questionsmedicales.fr/mesh/D014612",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins",
"code": {
"@type": "MedicalCode",
"code": "D014612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vaccins atténués",
"alternateName": "Vaccines, Attenuated",
"code": {
"@type": "MedicalCode",
"code": "D014613",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Aitor Nogales",
"url": "https://questionsmedicales.fr/author/Aitor%20Nogales",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com."
}
},
{
"@type": "Person",
"name": "Charles Grose",
"url": "https://questionsmedicales.fr/author/Charles%20Grose",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA."
}
},
{
"@type": "Person",
"name": "Manish Patel",
"url": "https://questionsmedicales.fr/author/Manish%20Patel",
"affiliation": {
"@type": "Organization",
"name": "Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov."
}
},
{
"@type": "Person",
"name": "Jessie R Chung",
"url": "https://questionsmedicales.fr/author/Jessie%20R%20Chung",
"affiliation": {
"@type": "Organization",
"name": "Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Implications of NKG2A in immunity and immune-mediated diseases.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/36032104",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.960852"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of lymphocytes, macrophages and immune receptors in suppression of tumor immunity.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36631195",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/bs.pmbts.2022.10.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vitamin D: immune function, inflammation, infections and auto-immunity.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36857810",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/20469047.2023.2171759"
}
},
{
"@type": "ScholarlyArticle",
"name": "The systemic immune response in Parkinson's disease: focus on the peripheral immune component.",
"datePublished": "2023-08-17",
"url": "https://questionsmedicales.fr/article/37598092",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tins.2023.07.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37578634",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/imr.13262"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins atténués",
"item": "https://questionsmedicales.fr/mesh/D014613"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins atténués - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins atténués",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins atténués",
"description": "Comment savoir si un vaccin est atténué ?\nQuels tests pour vérifier l'efficacité d'un vaccin atténué ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Immunity#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins atténués",
"description": "Quels symptômes peuvent apparaître après un vaccin atténué ?\nLes vaccins atténués causent-ils des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Immunity#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins atténués",
"description": "Comment se préparer avant de recevoir un vaccin atténué ?\nLes vaccins atténués sont-ils sûrs pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Immunity#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins atténués",
"description": "Que faire en cas de réaction sévère à un vaccin atténué ?\nLes vaccins atténués nécessitent-ils un traitement préventif ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Immunity#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins atténués",
"description": "Quelles complications peuvent survenir avec un vaccin atténué ?\nLes complications des vaccins atténués sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Immunity#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins atténués",
"description": "Qui devrait éviter les vaccins atténués ?\nLes antécédents d'allergies influencent-ils la vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D014613?mesh_terms=Immunity#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment savoir si un vaccin est atténué ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins atténués contiennent des agents pathogènes vivants, mais modifiés pour être moins virulents."
}
},
{
"@type": "Question",
"name": "Quels tests pour vérifier l'efficacité d'un vaccin atténué ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques peuvent mesurer la réponse immunitaire après vaccination."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après un vaccin atténué ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes bénins comme fièvre légère ou douleur au site d'injection peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués causent-ils des maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais ils peuvent provoquer des symptômes légers similaires à la maladie ciblée."
}
},
{
"@type": "Question",
"name": "Comment se préparer avant de recevoir un vaccin atténué ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informez votre médecin de vos antécédents médicaux et allergies avant la vaccination."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués sont-ils sûrs pour tous ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne conviennent pas à certaines personnes, comme celles immunodéprimées."
}
},
{
"@type": "Question",
"name": "Que faire en cas de réaction sévère à un vaccin atténué ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter immédiatement un professionnel de santé pour évaluer la situation."
}
},
{
"@type": "Question",
"name": "Les vaccins atténués nécessitent-ils un traitement préventif ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, mais des antécédents médicaux doivent être évalués avant la vaccination."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un vaccin atténué ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des infections chez les personnes immunodéprimées."
}
},
{
"@type": "Question",
"name": "Les complications des vaccins atténués sont-elles fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles sont rares et généralement bénignes, mais nécessitent une surveillance."
}
},
{
"@type": "Question",
"name": "Qui devrait éviter les vaccins atténués ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées ou enceintes doivent éviter ces vaccins."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies influencent-ils la vaccination ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies graves peuvent nécessiter une évaluation préalable."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Vaccins atténués" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. aitor_nogales@hotmail.com.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Infectious Diseases/Virology Laboratory, University of Iowa, Iowa City, IA 52242, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: aul3@cdc.gov.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia; JChung@cdc.gov.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA, USA. weger@vt.edu.
Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, Virginia Tech, Blacksburg, VA, USA. weger@vt.edu.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. piblanlo@gmail.com.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14642, USA. luis_martinez@urmc.rochester.edu.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, USA.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, School of Medicine and Dentistry, University of Rochestergrid.16416.34, Rochester, New York, USA.
Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Baylor Scott & White Health, Temple, TX, United States; Texas A&M University College of Medicine, Temple, TX, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.
Publications dans "Vaccins atténués" :
2 publications dans cette catégorie
Affiliations :
Texas Biomedical Research Institute, San Antonio, TX, USA. Electronic address: lmartinez@txbiomed.org.
Publications dans "Vaccins atténués" :
In recent studies, NKG2A is revealed to be a key immune checkpoint for both natural killer (NK) cells and CD8...
Cancer is now the leading cause of mortality across the world. Inflammatory immune cells are functionally important in the genesis and progression of tumors, as demonstrated by their presence in human...
Vitamin D plays an active role beyond mineral metabolism and skeletal health, including regulation of the immune system. Vitamin D deficiency is widely prevalent, and observational studies link low vi...
During Parkinson's disease (PD), both the central nervous system (CNS) and peripheral nervous system (PNS) are affected. In parallel, innate immune cells respond early to neuronal changes and alpha-sy...
Immune checkpoint inhibitors (ICIs) are potentially life-saving cancer therapies that can trigger immune-related adverse events (irAEs). irAEs can impact any organ and range in their presentation from...
Urinary tract infection (UTI) caused by uropathogens is the most common infectious disease and significantly affects all aspects of the quality of life of the patients. However, uropathogens are incre...
Oral lichen planus (OLP) is a common chronic inflammatory disorder of the oral mucosa with an unclear etiology. Several types of immune cells are involved in the pathogenesis of OLP....
We used single-cell RNA sequencing and immune repertoire sequencing to characterize the mucosal immune microenvironment of OLP. The presence of tissue-resident memory CD8+ T cells are validated by mul...
We generated a transcriptome atlas from four OLP biopsy samples and their paired peripheral blood mononuclear cells (PBMCs), and compared them with two healthy tissues and three healthy PBMCs samples....
Our study provides insights into the immune ecosystem of OLP, serving as a valuable resource for precision diagnosis and therapy of OLP....
Skin is a frontline organ that is continuously exposed to external stimuli, including pathogens. Various immune cells reside in the skin under physiological conditions and protect the body from the en...
Antiretroviral therapy against human immunodeficiency virus (HIV) is effective in controlling viral replication but cannot completely eliminate HIV due to the persistence of the HIV reservoir. Innate ...
Background: In spite of many reports on persistent low CD4 T cell counts and change in immune-related gene expression level in patients with HIV infection, there is still uncertainty about significant...
Methods: In this study, 30 HIV-1-positive patients (15 patients with and 15 patients without DIR [control group]) were included. PBMCs of the patients were collected through density radient centrifuga...
Results: CD4 T cell counts were significantly lower in DIR patients than the control group (p < 0.01). While there was no significant difference in the relative expression levels of CD4, CCL5, IFN-γ, ...
Conclusion: Our findings suggest a significantly higher APOBEC3G expression level in patients with DIR, suggesting the potential role of APOBEC3G in patients with immunological discordance besides its...